Report Detail
Global iPSC-Derived Neural Progenitor Cells Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4724844 |
- 03 August, 2026 |
- Global |
- 101 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global iPSC-Derived Neural Progenitor Cells market size was valued at US$ 74.08 million in 2025 and is forecast to a readjusted size of US$ 202 million by 2032 with a CAGR of 15.2% during review period.
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer’s disease, Parkinson’s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
This report is a detailed and comprehensive analysis for global iPSC-Derived Neural Progenitor Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC-Derived Neural Progenitor Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for iPSC-Derived Neural Progenitor Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global iPSC-Derived Neural Progenitor Cells market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include STEMCELL Technologies, Merck, Applied StemCell, Axol Bioscience, Tempo Bioscience, Creative Bioarray, ACROBiosystems, ATCC, Cell Applications, AcceGen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
iPSC-Derived Neural Progenitor Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cryopreserved Cells
Cell and Media Kits
Differentiation Kits
Disease-Specific Cells
Custom or GMP-Compatible Cells
Other Formats
Market segment by Donor or Disease Background
Healthy Control Donor
Patient-Derived Disease Model
Gene-Edited Reporter Line
Immune-Matched or HLA Line
Custom Donor Background
Other Donor Background
Market segment by Differentiation Stage
Neural Stem Cells
Neural Progenitor Cells
Regional Neural Progenitors
Lineage-Committed Progenitors
Mature Neural Derivatives
Other Differentiation Stages
Market segment by Quality Grade
Research Use Only Grade
Assay-Ready Grade
Xeno-Free Defined Grade
GMP-Compatible Grade
Custom Validated Grade
Other Quality Grades
Market segment by Application
Neurological Disease Modeling
Neurotoxicity and Safety Testing
Drug Screening and Target Validation
Neural Differentiation and Organoid Culture
Regenerative Medicine Research
Other Applications
Major players covered
STEMCELL Technologies
Merck
Applied StemCell
Axol Bioscience
Tempo Bioscience
Creative Bioarray
ACROBiosystems
ATCC
Cell Applications
AcceGen
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe iPSC-Derived Neural Progenitor Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of iPSC-Derived Neural Progenitor Cells, with price, sales quantity, revenue, and global market share of iPSC-Derived Neural Progenitor Cells from 2021 to 2026.
Chapter 3, the iPSC-Derived Neural Progenitor Cells competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the iPSC-Derived Neural Progenitor Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and iPSC-Derived Neural Progenitor Cells market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of iPSC-Derived Neural Progenitor Cells.
Chapter 14 and 15, to describe iPSC-Derived Neural Progenitor Cells sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Cryopreserved Cells
- 1.3.3 Cell and Media Kits
- 1.3.4 Differentiation Kits
- 1.3.5 Disease-Specific Cells
- 1.3.6 Custom or GMP-Compatible Cells
- 1.3.7 Other Formats
- 1.4 Market Analysis by Donor or Disease Background
- 1.4.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Donor or Disease Background: 2021 Versus 2025 Versus 2032
- 1.4.2 Healthy Control Donor
- 1.4.3 Patient-Derived Disease Model
- 1.4.4 Gene-Edited Reporter Line
- 1.4.5 Immune-Matched or HLA Line
- 1.4.6 Custom Donor Background
- 1.4.7 Other Donor Background
- 1.5 Market Analysis by Differentiation Stage
- 1.5.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Differentiation Stage: 2021 Versus 2025 Versus 2032
- 1.5.2 Neural Stem Cells
- 1.5.3 Neural Progenitor Cells
- 1.5.4 Regional Neural Progenitors
- 1.5.5 Lineage-Committed Progenitors
- 1.5.6 Mature Neural Derivatives
- 1.5.7 Other Differentiation Stages
- 1.6 Market Analysis by Quality Grade
- 1.6.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Quality Grade: 2021 Versus 2025 Versus 2032
- 1.6.2 Research Use Only Grade
- 1.6.3 Assay-Ready Grade
- 1.6.4 Xeno-Free Defined Grade
- 1.6.5 GMP-Compatible Grade
- 1.6.6 Custom Validated Grade
- 1.6.7 Other Quality Grades
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Neurological Disease Modeling
- 1.7.3 Neurotoxicity and Safety Testing
- 1.7.4 Drug Screening and Target Validation
- 1.7.5 Neural Differentiation and Organoid Culture
- 1.7.6 Regenerative Medicine Research
- 1.7.7 Other Applications
- 1.8 Global iPSC-Derived Neural Progenitor Cells Market Size & Forecast
- 1.8.1 Global iPSC-Derived Neural Progenitor Cells Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global iPSC-Derived Neural Progenitor Cells Sales Quantity (2021-2032)
- 1.8.3 Global iPSC-Derived Neural Progenitor Cells Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 STEMCELL Technologies
- 2.1.1 STEMCELL Technologies Details
- 2.1.2 STEMCELL Technologies Major Business
- 2.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
- 2.1.4 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 STEMCELL Technologies Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck iPSC-Derived Neural Progenitor Cells Product and Services
- 2.2.4 Merck iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 Applied StemCell
- 2.3.1 Applied StemCell Details
- 2.3.2 Applied StemCell Major Business
- 2.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
- 2.3.4 Applied StemCell iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Applied StemCell Recent Developments/Updates
- 2.4 Axol Bioscience
- 2.4.1 Axol Bioscience Details
- 2.4.2 Axol Bioscience Major Business
- 2.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
- 2.4.4 Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Axol Bioscience Recent Developments/Updates
- 2.5 Tempo Bioscience
- 2.5.1 Tempo Bioscience Details
- 2.5.2 Tempo Bioscience Major Business
- 2.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
- 2.5.4 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Tempo Bioscience Recent Developments/Updates
- 2.6 Creative Bioarray
- 2.6.1 Creative Bioarray Details
- 2.6.2 Creative Bioarray Major Business
- 2.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
- 2.6.4 Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Creative Bioarray Recent Developments/Updates
- 2.7 ACROBiosystems
- 2.7.1 ACROBiosystems Details
- 2.7.2 ACROBiosystems Major Business
- 2.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
- 2.7.4 ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 ACROBiosystems Recent Developments/Updates
- 2.8 ATCC
- 2.8.1 ATCC Details
- 2.8.2 ATCC Major Business
- 2.8.3 ATCC iPSC-Derived Neural Progenitor Cells Product and Services
- 2.8.4 ATCC iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 ATCC Recent Developments/Updates
- 2.9 Cell Applications
- 2.9.1 Cell Applications Details
- 2.9.2 Cell Applications Major Business
- 2.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
- 2.9.4 Cell Applications iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Cell Applications Recent Developments/Updates
- 2.10 AcceGen
- 2.10.1 AcceGen Details
- 2.10.2 AcceGen Major Business
- 2.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
- 2.10.4 AcceGen iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 AcceGen Recent Developments/Updates
3 Competitive Environment: iPSC-Derived Neural Progenitor Cells by Manufacturer
- 3.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global iPSC-Derived Neural Progenitor Cells Revenue by Manufacturer (2021-2026)
- 3.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 iPSC-Derived Neural Progenitor Cells Manufacturer Market Share in 2025
- 3.4.3 Top 6 iPSC-Derived Neural Progenitor Cells Manufacturer Market Share in 2025
- 3.5 iPSC-Derived Neural Progenitor Cells Market: Overall Company Footprint Analysis
- 3.5.1 iPSC-Derived Neural Progenitor Cells Market: Region Footprint
- 3.5.2 iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
- 3.5.3 iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global iPSC-Derived Neural Progenitor Cells Market Size by Region
- 4.1.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2032)
- 4.1.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2032)
- 4.1.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2032)
- 4.2 North America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
- 4.3 Europe iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
- 4.4 Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
- 4.5 South America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
- 4.6 Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
- 5.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2021-2032)
- 5.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
- 6.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2021-2032)
- 6.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032)
7 North America
- 7.1 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
- 7.2 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
- 7.3 North America iPSC-Derived Neural Progenitor Cells Market Size by Country
- 7.3.1 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
- 7.3.2 North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
- 8.2 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
- 8.3 Europe iPSC-Derived Neural Progenitor Cells Market Size by Country
- 8.3.1 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
- 8.3.2 Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific iPSC-Derived Neural Progenitor Cells Market Size by Region
- 9.3.1 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
- 10.2 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
- 10.3 South America iPSC-Derived Neural Progenitor Cells Market Size by Country
- 10.3.1 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
- 10.3.2 South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa iPSC-Derived Neural Progenitor Cells Market Size by Country
- 11.3.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 iPSC-Derived Neural Progenitor Cells Market Drivers
- 12.2 iPSC-Derived Neural Progenitor Cells Market Restraints
- 12.3 iPSC-Derived Neural Progenitor Cells Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of iPSC-Derived Neural Progenitor Cells and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of iPSC-Derived Neural Progenitor Cells
- 13.3 iPSC-Derived Neural Progenitor Cells Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 iPSC-Derived Neural Progenitor Cells Typical Distributors
- 14.3 iPSC-Derived Neural Progenitor Cells Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on iPSC-Derived Neural Progenitor Cells. Industry analysis & Market Report on iPSC-Derived Neural Progenitor Cells is a syndicated market report, published as Global iPSC-Derived Neural Progenitor Cells Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of iPSC-Derived Neural Progenitor Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
